Analysis of Debt
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Income Statement
- Common-Size Balance Sheet: Assets
- Common Stock Valuation Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Total Debt (Carrying Amount)
Vertex Pharmaceuticals Inc., balance sheet: debt
US$ in thousands
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Current finance lease liabilities | ||||||
| Long-term finance lease liabilities | ||||||
| Total finance lease liabilities (carrying amount) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Current finance lease liabilities
- The current finance lease liabilities demonstrate a fluctuating trend over the period analyzed. Initially, the liabilities increased from 42,434 thousand US dollars at the end of 2020 to 46,900 thousand in 2021. This was followed by a decrease to 40,800 thousand in 2022. Subsequently, there was a notable rise to 50,600 thousand in 2023, before a significant drop to 5,200 thousand in 2024. This pattern indicates variability in short-term lease obligations, with a major reduction observed in the latest period.
- Long-term finance lease liabilities
- Long-term finance lease liabilities exhibit a consistent downward trend across the years. Starting from 539,042 thousand US dollars in 2020, the liabilities declined steadily each year, falling to 509,800 thousand in 2021, 430,800 thousand in 2022, 376,100 thousand in 2023, and further down to 112,800 thousand in 2024. This sustained reduction suggests a systematic decrease in long-term obligations related to finance leases, possibly reflecting repayment, renegotiation, or asset disposals.
- Total finance lease liabilities (carrying amount)
- The total finance lease liabilities, which represent the carrying amount, reflect a downward trend consistent with the long-term liabilities. The total decreased from 581,476 thousand US dollars in 2020 to 556,700 thousand in 2021, further dropping to 471,600 thousand in 2022 and 426,700 thousand in 2023. In 2024, there was a pronounced decline to 118,000 thousand. Overall, the total liabilities decreased by approximately 79.7% over the five-year span, indicating a significant reduction in the company's lease-related financial obligations.
Total Debt (Fair Value)
| Dec 31, 2024 | |
|---|---|
| Selected Financial Data (US$ in thousands) | |
| Total finance lease liabilities (fair value) | |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | |
Based on: 10-K (reporting date: 2024-12-31).
Weighted-average Interest Rate on Debt
Weighted-average discount rate, finance leases:
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| Total | |||
Based on: 10-K (reporting date: 2024-12-31).
1 US$ in thousands
2 Weighted-average interest rate = 100 × ÷ =